SCHEMBL8557413

SCHEMBL8557413

O=C(Nc1nc(-c2ccccc2)c(Br)s1)c1cc2ccccc2[nH]1

nearest known ligand 0.61

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
NPC1 O15118 2/20 0.55
RAB9A P51151 2/20 0.55
SMN1; SMN2 Q16637 2/20 0.55
LMNA P02545 1/20 0.55
EGFR P00533 5/20 0.49
PIK3CA P42336 5/20 0.49
IDO1 P14902 1/20 0.48
ALDH1A1 P00352 2/20 0.48
KDM4E B2RXH2 2/20 0.48
GAA P10253 1/20 0.48
MAPK1 P28482 1/20 0.48
ADORA3 P0DMS8 1/20 0.47
KMT2A Q03164 1/20 0.46
MAPT P10636 1/20 0.46
DAO P14920 1/20 0.46
HPGD P15428 1/20 0.46
SRD5A2 P31213 1/20 0.46
HSD17B10 Q99714 1/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8562358 0.87 NPC1 (0.56) NPC1RAB9ASMN1; SMN2LMNAEGFR
SCHEMBL8559376 0.85 RAB9A (0.54) NPC1RAB9ASMN1; SMN2LMNAEGFR
SCHEMBL8558464 0.80 TRPV4 (0.50) NPC1RAB9ASMN1; SMN2LMNAEGFR
SCHEMBL8556757 0.79 MEN1 (0.66) SMN1; SMN2LMNAALDH1A1KDM4EKMT2A
SCHEMBL8557533 0.78 NPC1 (0.46) NPC1RAB9ASMN1; SMN2LMNAEGFR
SCHEMBL8557539 0.78 TRPV4 (0.46) NPC1RAB9ASMN1; SMN2LMNAEGFR
SCHEMBL8561965 0.76 NPC1 (0.52) NPC1RAB9ASMN1; SMN2LMNAEGFR
SCHEMBL8561960 0.76 NPC1 (0.52) NPC1RAB9ASMN1; SMN2LMNAEGFR
SCHEMBL17433464 0.76 DYRK1A (0.57) NPC1RAB9ASMN1; SMN2LMNAIDO1
SCHEMBL17433466 0.76 RAB9A (0.57) NPC1RAB9A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0518731-B1 2-(Indol-2-yl-carbonylamino)-thiazole derivatives, their preparation and pharmaceutical compositions containing them SANOFI SA (FR) 1998-08-26 EP disclosed
US-5380736-A Cholecystokinin and gastric antagonist ELF SANOFI (FR) 1995-01-10 US disclosed
US-5314889-A Hormone antagonists ELF SANOFI (FR) 1994-05-24 US disclosed
EP-0518731-A1 Heterocyclic derivatives of substituted 2-acylamino 5-thiazole, their preparation and pharmaceutical compositions containing them SANOFI (FR) 1992-12-16 EP disclosed